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Abstract
Background: Since 2007, the German statutory health insurance covers Specialized Outpatient Palliative Care
(SAPV). SAPV offers team-based home care for patients with advanced and progressive disease, complex symptoms
and life expectancy limited to days, weeks or months. The introduction of SAPV is ruled by a directive (SAPV
directive). Within this regulation, SAPV delivery models can and do differ regarding team structures, financing
models, cooperation with other care professionals and processes of care. The research project SAVOIR is funded by
G-BA’s German Innovations Fund to evaluate the implementation of the SAPV directive.
Methods: The processes, content and quality of SAPV will be evaluated from the perspectives of patients, SAPV
teams, general practitioners and other care givers and payers. The influence of different contracts, team and
network structures and regional and geographic settings on processes and results including patient-reported
outcomes will be analyzed in five subprojects: [1] structural characteristics of SAPV and their impact on patient care,
[2] quality of care from the perspective of patients, [3] quality of care from the perspective of SAPV teams, hospices,
ambulatory nursing services, nursing homes and other care givers, content and extent of care from [4] the
perspective of General Practitioners and [5] from the perspective of payers.
The evaluation will be based on different types of data: team and organizational structures, treatment data based
on routine documentation with electronic medical record systems, prospective assessment of patient-reported
outcomes in a sample of SAPV teams, qualitative interviews with other stakeholders like nursing and hospice
services, a survey in general practitioners and a retrospective analysis of claims data of all SAPV patients, covered by
the health insurance fund BARMER in 2016.
Discussion: Data analysis will allow identification of variables, associated with quality of SAPV. Based on these findings, the
SAVOIR study group will develop recommendations for the Federal Joint Committee for a revision of the SAPV directive.
Trial registration: German Clinical Trials Register (DRKS): DRKS00013949 (retrospectively registered, 14.03.2018),
DRKS00014726 (14.05.2018), DRKS00014730 (30.05.2018). Subproject 3 is an interview study with professional caregivers and
therefore not registered in DRKS as a clinical study.
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Background
Corresponding to the Federal Statistical Office about 1%
of the population in Germany dies within a year [1] and
studies as well as the German Association for Palliative
Medicine (DGP) estimate that about 90% of these re-
quire some level of palliative care [2–5]. To facilitate un-
derstanding of palliative care provision in the German
health care system in the international community, we
use the terminology defined by the European Associ-
ation for Palliative Care (EAPC) in the “White Paper on
standards and norms for hospice and palliative care in
Europe” [6, 7]. According to the EAPC, palliative care
can be made available on three different levels: palliative
care approach, general palliative care and specialist pal-
liative care – whilst palliative care approach and general
palliative are often dealt as a joint category when focus-
ing on the contrast to specialist palliative care, as we will
do during this study protocol. While most patients with
a life-limiting disease may only require general palliative
care as provided by primary care professionals or spe-
cialists, a substantial amount of patients suffer from a
high burden of symptoms and therefore require special-
ist palliative care. In case of outpatient care in Germany,
general palliative care can be provided as General Out-
patient Palliative Care (AAPV) and patients with a need
for specialist palliative care can be referred to Special-
ized Outpatient Palliative Care (SAPV). SAPV is regu-
larly provided by multi-professional home palliative care
teams, comprising at least physicians and nurses, deliv-
ering specialized palliative care at the homes of patients
with complex needs and suffering from incurable, pro-
gressive and life-limiting diseases.
Since the German Act to Strengthen Competition in
Statutory Health Insurance (GKV-WSG) was introduced
in 2007, SAPV has been fully covered by the Statutory
Health Insurance [8] and can be prescribed by
outpatient physicians as general practitioners (GPs),or
by hospital physicians. Eligibility criteria as well as type
and extent of SAPV services are determined by the
SAPV directive of the Federal Joint Committee (G-BA,
the highest decision-making body of the joint self-gov-
ernment of physicians, dentists, hospitals and health in-
surance funds in Germany) [9]. The SAPV directive
defines objectives of SAPV (§1), eligibility requirements
(§2, §3), particularly complex care (§4), content and
scope of SAPV (§5), collaboration with other care pro-
viders (§6), prescription of SAPV (§7) and the assess-
ment of entitlement for benefits by health insurance
funds (§8). This directive has been worded in general
terms to enable health insurance funds and care pro-
viders to make individual agreements (selective contract-
ing), based on regional specifications and already
existing structures. The resulting regulations are highly
variable regarding care provision, cooperation and
quality assurance as well as financial reimbursement and
has led to different models [10]. This is reflected in over
290 different SAPV contracts nationwide [11], so that
team structures, cooperation with other care givers, pa-
tient inclusion and exclusion criteria, processes of care,
treatment intensity and financing models may differ sub-
stantially between the SAPV teams.
In 2016 about 55.000 patients (6% of the deceased in
Germany) had received SAPV [11] before their death.
This proportion is well below the estimated 10% of dying
patients with a need for specialist palliative care at home
[2]. However, recent analyses in Germany focused
mainly on the description of (regional) SAPV-structures
and utilization [12–16] as, for instance, the study “Fak-
tencheck Gesundheit” investigated regional disparities of
SAPV prescriptions [17]. Until now, no nationwide as-
sessment of SAPV from different perspectives has been
conducted [18]. In our view, there is a special need for
an evaluation of the SAPV directive taking into account:
1) The heterogeneity of organizational structures and
processes and their effects on patient care:
Heterogeneity is particularly represented by
different forms of ownership, team structure,
integration of different professions, reimbursement
systems and regional factors like urban or rural
settings [14]. This also leads to different levels of
involvement of the SAPV teams (consultation,
coordination of care, partial or full provision of
care). The potential consequences of these different
contractual elements on patients´ care are mostly
unknown.
2) As palliative care is a multi-professional, patient-
centered care model, different perspectives of
affected persons and involved professionals should
be considered [19].
a. Although the individual needs of patients and
their relatives are key aspects of the SAPV
directive, there are no formal requirements for a
corresponding quality assurance. Available
research does not focus on the patient
perspective at all [17] or only does so in specific
scenarios [14, 20]. Assessing quality of care
without consideration of the patients
perspective will remain incomplete [21]. With
the help of the questionnaire QUAPS (Quality
Assurance in Outpatient Palliative Care) we will
be able to investigate quality of SAPV from
patients’ perspective [22].
b. Since SAPV is acting in a complex social
environment of patients, relatives and health
care professionals, the evaluation of overall
quality of palliative care requires an adapted and
differentiated analysis considering cooperation
Freytag et al. BMC Palliative Care           (2019) 18:12 Page 2 of 9
and perspective of these stakeholders.
Accordingly, SAPV is a process of interactions
of these participants, located in the individual
patient’s environment. Therefore it is necessary
to describe the local cooperation of health care
professionals.
c. General practitioners (GP) are substantially
involved in the end of life care of their patients
[23]. They play an important role in AAPV, can
introduce SAPV to patients’ care by medical
prescription and often remain subsequently
involved [24]. This key role strengthens the
need of assessing the impact of GPs on the
quality of SAPV in connection to patients, other
health professionals and the SAPV directive.
3) The interface between general and specialist
outpatient palliative care appears to be under-
explored [11, 25]. Furthermore, available claims
data studies focused on a small selection of specific
aspects of palliative care [26]. Investigation of
utilization and costs of different types of palliative
care using claims data is a useful addition. On that
basis it might be possible to find hints for over-,
under- and missupply of end-of-life-care considering
health economic perspectives.
4) Against the background of the requirements of
the national ethics council [27], it is an
important goal to highlight the patients’ welfare
as the leading principle in medical care. Taking
this into account, it is necessary to focus on
potential shortage of outpatient palliative care in
specific patient groups, for example patients with
non-malignant disorders.
So far, a systematic and nationwide data assessment in
SAPV is lacking. In order to support the further devel-
opment of SAPV and the guiding SAPV directive, it is
necessary to assess the process, extent and quality of
SAPV and their determining factors. For this purpose,
SAVOIR (Evaluation of the SAPV directive, Outcomes,
Interactions and regional variations) was funded by the
German Innovations Fund (launched by the Federal
Joint Committee) to evaluate the execution of the SAPV
directive and to present suggestions for a revision of the
SAPV directive.
The project is performed by the Department of Pallia-
tive Care (coordinator), Institute of General Practice and
Family Medicine (both Jena University Hospital), Clinic
for Palliative Medicine (University Medical Center Göt-
tingen), Center for Interdisciplinary Health Research
(ZIG, University of Augsburg), German federal associ-
ation for SAPV (BAG-SAPV), German Association for
Palliative Medicine (DGP) and the health insurance fund
BARMER.
Methods/design
Aim of the study
The project will study care provision in SAPV from the
perspective of patients, SAPV teams, other care givers,
GPs and payers. The influence of different contracts,
team and network structures, regional and geographic
settings on processes and results including
patient-reported outcomes will be analyzed. This will be
carried out in five subprojects:
Subproject 1: The aim is to investigate the structural
characteristics of SAPV (determined by contracts and
organizational team structures) and assess if and how
these aspects influence patient care.
Subproject 2: The aim is to investigate the quality of
care from the perspective of patients.
Subproject 3: The aim is to estimate the quality of
care from the perspective of SAPV teams and external
network partners such as hospices, ambulatory nursing
services, nursing homes and other care givers.
Subproject 4: The aim is to investigate the type and
extent of GPs palliative care with and without SAPV and
the quality of palliative care from their perspective.
Subproject 5: The aim is to describe and distinct dif-
ferent types of palliative care, the patients receiving
these types of care, their health care utilization and qual-
ity of care in its regional variations by means of health
insurance fund claims data.
Primarily, mixed-methods data analysis will allow the
identification of variables that influence care provision
and may be associated with quality of SAPV. Based on
these findings, the SAVOIR study group will provide rec-
ommendations for the revision of the SAPV directive for
the Federal Joint Committee.
Design and setting
The project will be based on different data sources: sub-
project 1a) registry data on team and organizational
structures from the German Guide for hospice and
palliative care services as well as model contracts in all
German regions and 1b) clinical routine patient data
from electronic medical record (EMR) of a sample of
SAPV teams, subproject 2) patient-reported outcomes in
a sample of about 50 SAPV teams, each collecting data
from 25 patients, subproject 3) qualitative interviews
with members of SAPV teams and linked providers in-
volved in SAPV, like nursing and hospice services, sub-
project 4) survey data from GPs and subproject 5)
health insurance fund claims data from patients who
have died in 2016 and were covered by the health insur-
ance fund BARMER.
This study is conducted in Germany from July 2017 to
June 2019 and includes a transdisciplinary and multi-method
design. The overall project is characterized by a cross-project
use of data and a combination of quantitative and qualitative
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research designs. The focus of the quantitative re-
search is obtaining a representative cross-section of
the German SAPV, for instance by mapping the 17
Regional Associations of Statutory Health Insurance
Physicians (KV). These regions are equivalent to the 16
Federal German States, but North Rhine-Westphalia is di-
vided into North Rhine and Westphalia-Lippe.
From a sample of about four SAPV teams per KV, ag-
gregated data of approximately 70 patients per SAPV
team are associated to structural characteristics of the
selected teams (subproject 1). Following this, a patient
survey of a sub-group of about 25 patients per SAPV
team will be conducted, focusing on the quality of care
from the perspective of patients and on linking these
findings to individual demographic and clinical data
(subproject 2). A postal survey of about 1200 GPs using
a standardized, quantitative study design in eight KV do-
mains is conducted to explore their involvement in and
needs regarding SAPV (subproject 4). An analysis of pal-
liative care based on claims data [17, 28], provided by
the health insurance fund BARMER, is performed to
represent the utilization of the different types of in- and
outpatient palliative care services in Germany (subproj-
ect 5). Data which cannot be obtained via quantitative
research designs – such as interpretations and evalu-
ation categories of quality of care by SAPV teams and
their network of care givers and service providers –
will be explored by a qualitative design. This is
carried out as an on-site field study involving com-
parative case studies. Ten SAPV teams, each of which
represents a minimal or maximal type within a set of
contrasting structural characteristics, will be explored
by means of field trips of several days duration (sub-
project 3). Wherever possible, synergies between the
SAVOIR subprojects will be used. This involves the
exchange of data (e.g. regarding the empirically
grounded selection criteria for SAPV teams) and co-
operation regarding content and concept of the
subprojects.
Data management
The data management and all required steps of data
preparation (for example check for plausibility and in-
tegrity) will be located at the Center for Clinical Trials
at University Hospital Jena. All participant data will be
pseudonymized. In addition, data collected from the
subprojects will be managed at the corresponding insti-
tution: in subproject 4, data from the survey will be an-
onymously evaluated. The claims data analysis in
subproject 5 will be based on the recommendations of
the “Good Practice Secondary Data Analysis” [29]. The
data management of subproject 3 will be located at the
Center for Interdisciplinary Health Research (ZIG) at
the University of Augsburg.
Ethics
Votes from the local ethics committees of the respective
institutions were obtained from Jena University Hospital
(No. 5312–10/17, 5316–10/17, 5317–10/17), University




Structural characteristics of SAPV and their impact on
quality of care.
Hypotheses Differences in provision of care are associated
with different team structures and regulatory foundations.
Method and Design The study encompasses three
steps. Step 1a: Assesses SAPV structures nationwide (in
cooperation with the DGP). Step 1b: Assesses regulatory
structures, specifically the contracts between health in-
surance funds and SAPV teams (in cooperation with the
BAG-SAPV). Step 2: SAPV teams provide patient data
prospectively for 6 months. The patient data will be ana-
lyzed regarding regional and structural differences.
Study population Step 1a/1b: Comprehensive assess-
ment of SAPV teams and contracts. Step 2: Recruit-
ment of 4 teams per region (n = 17). Assessment of
70 patients per team in six months, resulting in 5.950
patient data sets.
Data collection Step 1a: In 2017, all institutions provid-
ing SAPV in Germany were asked to submit data to the
guide for hospice and palliative care services (Wegweiser
“Hospiz- und Palliativversorgung”), an online data base
provided by the DGP. The guide is based on voluntary
information given by institutions and contains data of
270 SAPV providers. As there is no existing comprehen-
sive list of SAPV providers in Germany, the guide con-
tains the largest existing list of SAPV teams. Step 1b:
The contracts will be analyzed regarding their differ-
ences in regulation. In order to validate information and
assess different practices, interviews with local SAPV
providers or stakeholders, who are involved in policy
making, are conducted. Step 2: Coded patient data is ex-
tracted through two widely used electronic medical re-
cords (EMR) software solutions in Germany: PalliDoc
(StatConsult) and ISPC (Smart-Q). Data assessment is
based on the consented data set for a nationwide hos-
pice and palliative care registry. Few additional items will
be assessed (number of visits, number of hospital addi-
tions, socioeconomic status). SAPV teams ask all pa-
tients admitted to SAPV during six month for
permission for data extraction.
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Data analyses Step 1a/1b: Structural and contract vari-
ables will be analyzed descriptively. Step 2: Hierarchical
multilevel models will be used to analyze associations
between structural predictors and the patient and care
parameters.
Subproject 2
Quality assurance in SAPV – a quantitative collection of
data from patients´ perspective.
Hypotheses Patients´ perspective on quality of care in
SAPV is correlated to structures and processes of SAPV
teams.
Method and Design With a questionnaire, called
QUAPS [22], developed to assess quality of care with
SAPV, patients report their perspective on quality of
symptom control, processes of care and results. In
addition, IPOS (Integrated Palliative care Outcome
Scale) is assessed at the time of inclusion (IPOS base-
line) and about 3–14 days after inclusion (IPOS
follow-up).
Study population Data from 25 consecutive patients
from 50 SAPV teams covering the 17 KV regions are
collected over a maximal period of 6 months, resulting
in data from 1250 patients.
Data collection Data of all patients cared for by the
SAPV team within the period are collected with subproj-
ect 1 via export from the EMR system (PalliDoc or
ISPC). The IPOS and QUAPS questionnaires are col-
lected by the local SAPV team and sent in a closed enve-
lope to the study center.
Data analyses Data analysis is descriptive. IPOS baseline
data are compared to IPOS follow-up data. QUAPS data
are compared between SAPV teams. In a further step,
data of subproject 2 are analyzed for their association
with data on structures and processes of SAPV teams,
collected by subproject 1.
Subproject 3
Beneficial and inhibiting factors for a successful per-
formance of SAPV teams from the perspective of SAPV
team members and network partners.
Hypotheses The self-perception, working strategies, team
cultures and organizational structures of SAPV teams are
influenced by patient-, payment-, organization-, region-
and structure-related factors.
Method and Design We develop and carry out
problem-centered interviews within the framework of an
ethnographic qualitative study design by means of
on-site field studies based on grounded theory. The aim
of grounded theory research is not only to “uncover rele-
vant conditions but also to determine how the actors
under investigation actively respond to those conditions
and to the consequences of their actions” [30]. Basic ele-
ments of a research approach according to the grounded
theory are the following: Data analysis begins with the
first bits of data available, further collection of data is
based on the ongoing process of data analysis all along
the duration of a research project. Any outcome of the
data analysis such as concepts and categories are con-
stantly contrasted and compared, e.g. similar situations
discovered in various interviews are compared. This is
also an important means to evaluate the findings. Thus,
concepts discovered at the beginning of the research
process are likely to have completely changed till the
end of the research.
Study population The study population is centered on
10 SAPV teams and their environment, i.e. their external
network partners as well as other local care providers -
if possible even those who deliberately chose not to co-
operate with the SAPV team. The selection is deter-
mined by various categories such as size of team,
economic prosperity of region, population density,
organizational contexts, etc. The aim is to gather infor-
mation from a broad spectrum of teams and to contrast
certain categories as much as possible, for example a
contrast between teams in rural vs. teams in urban areas
or completely autonomous teams vs. teams embedded in
a wider organizational context like hospitals or hospices.
Data collection The data is being collected mainly by
means of qualitative, problem-centered interviews. Inter-
views are being conducted on-site with SAPV team
members such as team-managers, physicians, palliative
care nurses, counselors and external network partners
like GPs, retirement homes, palliative care units in hos-
pitals, pharmacies and medical stores. Topics of the
interview guidelines include daily working habits, char-
acteristics of patients and team dynamics as well as fu-
ture and structural effects of SAPV in the local area.
The research-team also uses the technique of field notes
to provide a wider context around the interviews.
Data analysis We are conducting a qualitative analysis
within the grounded theory framework. This involves in-
ductive and deductive analysis of interview data.
Subproject 4
General Practitioners‘care for palliative patients within
and outside SAPV (GPs‘perspective).
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Hypotheses: The self-perception and tasks of GPs in
palliative care in general and the prescription of SAPV
by GPs in particular are determined by patient-, phys-
ician-, qualification-, payment-related and other environ-
mental (i.e. palliative infrastructure) factors.
Method and Design Based on a literature search for
criteria to measure the role of the GP in palliative care,
the following steps are part of the project: Step 1: Defin-
ition and evaluation of corresponding questions for the
qualitative analysis of interviews with GPs in cooper-
ation with subproject 3 and in preparation for the subse-
quent quantitative analysis. Step 2: Quantitative analysis
of a GP survey. Step 3: Synthesis of the results of the
qualitative and quantitative analysis as well as the claims
data analysis (subproject 5) with the aim to derive cri-
teria for a systematic description of the GP’s involvement
in AAPV and SAPV. The development of the question-
naire (step 2) is based on a literature search and
semi-structured interviews with GPs and palliative care
specialists. Pretests are performed before finalizing the
questionnaire.
Study population Random sample of 6000 GPs in the
federal states of Bavaria, Berlin, Hesse, Lower Saxony,
Saxony-Anhalt, Schleswig-Holstein, Thuringia and
Westphalia-Lippe as a part of North Rhine-Westphalia.
The selection is based on the structure of regional SAPV
contracts as well as the number of inhabitants and size
to represent the heterogeneity of SAPV in Germany.
Data collection The GP address data are collected via
free-access internet portals or obtained from the Re-
gional Association of Statutory Health Insurance Physi-
cians. The postal questionnaire is addressed to 750 GPs
in each survey area. Survey data will be transcribed into
a database electronically. Within a standardized, quanti-
tative study design, a postal survey with 750 GPs from
eight regions each is performed in 2018. The regions
were selected in consideration of the different structural
characteristics of SAPV in Germany, evaluated in sub-
project 1, to represent differences in the regions. The ex-
pected response rate is 20% (n = 1200).
Data analyses We will conduct a descriptive analysis of
quantitative variables and will also perform univariate
and multivariate regression analyses on the association
between independent and dependent variables.
Subproject 5
SAPV in comparison to other types of palliative care: pa-
tient characteristics and resource utilization (payer’s
perspective).
Hypotheses: The type, extent and quality of palliative
care a patient receives during the last months before
death differs according to patient characteristics as well
as regional structures of palliative care provision.
Method and Design We perform a retrospective cohort
study in a cross-sectional design with a subgroup ana-
lysis. By means of pseudonymized master data, people
insured with the health insurance fund BARMER who
died in 2016 (study population) are identified. It will be
determined if patients received palliative care and if yes,
what level of palliative care with regard to general or
special palliative care, in- or outpatient palliative care, or
combinations thereof, they received within the last six
months before their death. On this basis, we will assign
the patients to the study cohorts.
Study population About 95,000 adults throughout
Germany, insured, with the health insurance fund BARMER
and time of death in the year 2016.
Data collection Pseudonymous individual claims data
(according to §§ 284, 295, 300, 301, 302 of the Fifth
Book of the Social Code, SGB V) are made available via
the Scientific Data Warehouse of the health insurance
fund BARMER. Additional variables and value lists,
which are considered relevant for the planned investiga-
tion (i.e. specific billing codes for AAPV and SAPV as
well as hospices care data), were supplemented. Relevant
periods of observation of received health insurance fund
services include the last six and three months before
death, the time period between months 12 and seven be-
fore death is defined as pre-observation period. The as-
signment of patients to cohorts and subgroups is
executed by means of defined outpatient billing codes or
hospital-based operation and procedure codes (OPS).
We use preexisting indicators and – under consideration
of the limitations of claims data - develop and quantify
new and eligible indicators to describe distinct types of
palliative care, their utilization and their quality of care.
The study population will be characterized by
socio-economic, administrative diagnoses and other
care-specific attributes. In addition, we will calculate
measures aimed at describing the quality of palliative
care based on variables available in claims data.
Data analyses Outcome measures and patient charac-
teristics will be described statistically for each cohort
and region. For the comparison of outcome measures
between cohorts and regions we intend to use multivari-
ate regression analyses.
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Discussion
Recent analyses in Germany focused mainly on the de-
scription of (regional) SAPV structures and utilization
[12–15, 17]. A nationwide assessment of SAPV from dif-
ferent and relevant perspectives has not yet been con-
ducted. To provide this, SAVOIR addresses: [1] the
structural characteristics of SAPV and their impact on
patient care, [2] the quality of care from the perspective
of patients, [3] the quality of care from the perspective
of SAPV teams, hospices, ambulatory nursing services,
nursing homes and other care givers, [4] the content
and extent of care from the perspective of GPs and [5]
the health insurance fund as a payer. The comprehen-
sive, nationwide data assessment in the SAVOIR study
uses different perspectives and data sources as well as
both quantitative and qualitative methods. This allows
us to identify the current conditions and special needs in
palliative care from patients, relatives, care providers
and payers in Germany. Subsequently we will compare
different care models and provide an overview of SAPV
provision in Germany and moreover we will provide an
in-depth analysis of differences - even if we will not be
able to take the entirety of differences into account.
Based on these findings, factors related with high quality
of care in SAPV will be identified.
Although SAVOIR uses multi-method and transdis-
ciplinary approach with unique advantages, clinical re-
search in patients with an advanced and life-limiting
disease remains challenging, i.e. with regard to suit-
able research methods as well as the participation of
healthcare professionals and the recruitment of pa-
tients [31–34].
According to the different research strategies in each
subproject, we are conscious of the following limitations:
Subproject 1: In step 1a, teams may not provide their
real personnel structures, but rather a socially desirable
version. The interviews were conducted via phone,
which may increase this effect. The regulatory contracts
may not cover the “real care provision”, as there may be
regional differences that were not captured in the inter-
views and that we are unaware of. Some regions have
model contracts, but specific characteristics like financial
reimbursement may still vary between teams. To assess
patient care, we use clinical routine data. While our pro-
spective assessment enables us to give the teams infor-
mation about the extracted data in advance and thus
provide a better data quality, clinical routine data still is
difficult to interpret. The variables used may be differ-
ently understood by those who document them and thus
result in various interpretations within and between col-
lecting SAPV teams.
Subproject 2: Questioning palliative patients and their
relatives can only be pursued under several limitations:
Patients are often in a poor general condition,
participation in research is an additional burden for
them and palliative care teams are often not experienced
in clinical research and are reluctant to address partici-
pations. A specific challenge is given by the fact that life
expectancy in SAPV patients is often limited to days or
few weeks and treatment ends in most cases with the
death of the patient. Therefore, in contrast to most other
types of care, it is not possible to approach patients at
the end of SAPV treatment. On the other hand, patients
have to have experienced a certain time of SAPV care
before they can report on its quality. Therefore, there is
only a small time window to obtain patient-reported in-
formation on quality of SAPV care [35]. This may reduce
the sample size and those participating may be a selected
group of relatively “healthy” patients. However, pilot
testing has revealed that the chosen approach will result
in a sufficient number of data sets. Therefore we con-
duct a multi-method design, collecting treatment data of
all patients agreeing to participate in subproject 1 over
the time of recruitment for subproject 2.
Subproject 3: The field survey may lead to
self-selection of participating SAPV teams: We expect
that SAPV teams interested in research and improve-
ment of palliative care will be more likely to participate.
A measure to prevent self-selection of SAPV teams is
the purposeful selection of participants via a set of vari-
ous criteria such as the size of the team, economic pros-
perity of region, population density, organizational
contexts, etc. Furthermore SAPV teams themselves se-
lect external network partners for the interviews. We ex-
pect that only external network partners are chosen for
participation who are highly motivated, interested in pal-
liative care and have positive experiences in working to-
gether with SAPV teams. Especially GPs with a more
reserved attitude towards SAPV are unlikely to partici-
pate. This aspect is methodologically reflected during
the data analysis.
Subproject 4: In the GP survey we have to deal with
the fact that GPs more interested, qualified and/or expe-
rienced in end-of-life care might be more willing to par-
ticipate in the survey than others. Therefore, we request
information on the extent, experience and qualification
in terms of palliative care from the GPs to be able to de-
termine the impact of these factors on the results.
Subproject 5: Though the BARMER made great ef-
forts to collect all relevant data on SAPV and to transfer
it into the Scientific Data Warehouse, the claims data
base on SAPV will not be fully complete by the end of
the project and may not cover all existing health services
within SAPV in Germany. The data do not contain full
information on the qualification levels of care providers
necessary to finer differentiate between levels of pallia-
tive care such as palliative care approach and general pa-
tient care. Apart from many advantages in analyzing
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claims data, their information value for the measure-
ment of quality of care is restricted due to the lack of
clinical and patient reported data.
To sum up, SAVOIR – consisting of five subprojects –
will provide important information on the complex and
regionally varying structures, processes, extent and qual-
ity of SAPV in Germany and the factors which deter-
mine the quality of SAPV from the different perspectives
of stake-holders involved. We aim at deriving recom-
mendations to further develop the SAPV directive. The
results will add valuable knowledge on starting points to
improve outpatient palliative care, mainly in Germany,
that might be applicable for other countries, too.
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